Tectonic Therapeutic | AVRO - Процентные расходы





Процентные расходы Изменить Дата
Akebia Therapeutics 349.66M 12.86M 2026-06
Alnylam Pharmaceuticals USD 82.05M 12.76M 2026-06
Celltrion KRW 19B 1.96B 2025-06
Cspc Pharmaceutical CNY 6.76M 3.43M 2025-12
Deva Holding AS TRY 272.53M 69.04M 2023-09
Dianthus Therapeutics USD 4.44M 263K 2024-09
Divis Laboratories Ltd INR 60M 0 2026-06
Gilead Sciences USD 247M 7M 2026-06
Ionis Pharmaceuticals USD 18M 1000K 2026-06
Kangmei Pharma CNY 1.82M 150K 2025-09
Karyopharm Therapeutics USD 12.55M 66K 2026-03
Knight Therapeutics CAD 3.92M 1.56M 2025-12
Laboratorios Farma EUR 699K 666.2K 2025-06
MacroGenics USD 4.89M 1.55M 2026-03
Medical Developments International AUD 18K 3K 2025-06
Neuren Pharmaceuticals AUD 0 0 2024-06
Organigram Holdings CAD 179K 127K 2025-03
Ovoca Bio EUR 7K 6K 2022-06
Pfizer USD 667M 4M 2026-06
Pharma Mar EUR 117K 1.24M 2025-09
Qiagen NV USD 10.02M 1.03M 2026-06
Roche Holding CHF 304M 7.5M 2025-06
Sangamo BioSciences 97.56M 11.39M 2025-06
Sanofi EUR 287M 109M 2026-06
Sarepta Therapeutics USD 21.51M 205K 2026-06
Sartorius EUR 49.5M 8.1M 2025-09
Sino Biopharmaceutical CNY 76.87M 114.23M 2024-06
Takeda JPY 63.85B 20.2B 2026-06
Tilray USD 6.7M 2.73M 2025-06
Zealand Pharma A/S 7.07M 74K 2025-12
Zz Pientze Pharmaceu CNY 46.05M 36.5M 2025-06